Aegis Pharma Gateway | Fast-Track Your Pharmaceuticals into Europe
Aegis Pharma Gateway
EU GMP / GDP Compliant Platform · Northern Greece

Fast-Track Your Pharmaceuticals into Europe

APG is establishing a pharmaceutical packaging and logistics hub in Northern Greece — combining serialization, cold-chain handling and multi-modal distribution in a single, regulation-ready gateway into Central and Eastern Europe.

50%
Faster to CEE vs. northern European ports*
24h
Minimum road time to nearest CEE markets
1
Single compliant EU entry point
Multimodal Pharmaceutical Corridor
India / Gulf Region Origin markets · IMEC corridor
Origin
APG — Northern Greece Package · Serialize · Release
Hub
Bulgaria · Romania · Ukraine CEE markets · 6–36h by road
Markets
Time advantage vs. northern ports Up to 50% faster
EU GMP Aligned · GDP Compliant · EU FMD Serialization · QP-Supervised Batch Release · Multimodal Logistics · Cold Chain 2–8°C · EU GMP Aligned · GDP Compliant · EU FMD Serialization · QP-Supervised Batch Release · Multimodal Logistics · Cold Chain 2–8°C ·

Why APG — Why Now

A convergence of trade policy, infrastructure investment and regulatory change is opening a rare window for a purpose-built pharmaceutical gateway in Southern Europe.

IMEC & EU–India FTA

The India–Middle East–Europe Economic Corridor positions the Eastern Mediterranean as the key link for Indo-Pacific pharmaceutical trade flows.

EU Pharma Legislation Reform

Revised EU directives are tightening serialization, packaging and batch release rules — making a single, pre-compliant EU hub more valuable than ever.

Vertical Corridor Infrastructure

Billions in CEF II, EIB and RRF funding are upgrading the North-South rail/road corridor through Greece and the Balkans — APG sits at its Mediterranean terminus.

Strategic Route

Connects maritime flows from India and the Gulf to the Eastern Mediterranean, with onward rail and road into Central and Eastern Europe.

Single EU Entry Point

One shared, compliant platform to package, prepare and dispatch products into multiple EU markets — no need for multiple local structures.

Regulation-Ready by Design

Packaging, serialization and batch release structured from day one around EU market entry requirements — so your product arrives shelf-ready, not subject to re-work or re-testing.

Changing Trade Landscape

IMEC, the Vertical Corridor and deeper EU–India ties create a timely opportunity for a new pharmaceutical gateway focused on speed and resilience.

Full-Spectrum Services

Everything You Need to Enter Europe

From bulk import to country-ready packs — one integrated platform, one point of regulatory accountability.

Secondary & Tertiary Packaging

Market-ready packaging under EU GMP, including country-specific labeling, leaflet management and late-stage customization for every target market.

EU GMP

Serialization & Aggregation

EU and UK FMD-compliant serialization and aggregation up to pallet level, supporting full traceability and pack integrity from manufacturer to patient.

EU FMD Compliant

Cold Chain & Warehousing

Temperature-controlled storage (2–8°C for biosimilars and biologics), bonded and non-bonded warehousing for high-value, time-sensitive medicines.

2–8°C Controlled

Distribution into CEE

Rail and road dispatch through Northern Greece into Bulgaria, Romania, Ukraine and neighboring markets — with real-time tracking and flexible multi-drop capability.

Multi-Modal

QP-Supervised Batch Release

Batch release under Qualified Person supervision, ensuring full regulatory compliance for EU market entry. Dynamic batch redirection reduces inventory rigidity.

QP Supervision

Strategic Consulting

End-to-end optimization of pharma supply chains, GDP compliance design, cold chain lane qualification and facility planning — APG as your knowledge partner.

GDP / GMP Advisory

Built for Speed Without Shortcuts

APG’s facility converts bulk pharmaceuticals into commercial-ready, market-specific packs — engineered for throughput, traceability and audit-readiness from the ground up.

Temperature-Controlled Storage Zones

Dedicated 2–8°C and ambient zones with continuous monitoring for biosimilars and standard products.

Dedicated Secondary Packaging Suites

GMP-aligned packaging lines with version-controlled labeling, leaflet management and audit trails.

EU FMD Serialization & Aggregation

Full track-and-trace from unit pack to pallet, with direct EMVO connection and data integrity controls.

Secure Access & Controlled Material Flows

Zoned facility with restricted access, documented material flows and segregation protocols aligned to GMP requirements.

QP-Supervised Release Process

Qualified Person sign-off for each batch, with batch documentation review and release for EU market distribution.

Bonded & Non-Bonded Warehousing

Customs-bonded capacity for duty-deferred stock, enabling flexible release into multiple EU markets from a single inventory pool.

The Time Advantage That Changes Everything

Pharmaceutical logistics is time-critical. APG’s position at the Aegean gateway delivers a structural speed advantage over congested northern European ports — based on published port transit data and road/rail schedules on the Vertical Corridor.

Northern European Ports
72–96
hours to CEE markets

Rotterdam, Hamburg, Antwerp — longer transit, higher congestion risk, greater inventory exposure

VS
APG — Northern Greece
24–48
hours to CEE markets
Up to 50% Faster*

Faster replenishment · lower working capital · greater commercial agility

*vs. Rotterdam/Hamburg transhipment to Sofia, based on published port & rail transit data

Road Transport

Delivery to Central & Eastern Europe in 6–36 hours with flexible multi-drop distribution and real-time GPS tracking. Ideal for urgent and temperature-sensitive shipments.

Rail Transport

Ideal for large or temperature-sensitive volumes — stable, cost-efficient and seamlessly integrated into multimodal flows along the Vertical Corridor to Central Europe.

The Vertical Corridor: APG’s Infrastructure Backbone

The Vertical Corridor links the Aegean Sea to Central Europe and Ukraine via road and rail, backed by billions in EU funding. APG sits at its southern anchor — the first compliant pharma facility on this critical route.

Project Sea2Sea (Greece – Bulgaria)

Connecting the ports of Northern Greece (Thessaloniki, Kavala, Alexandroupolis) with Bulgarian Black Sea ports (Burgas, Varna) and the Danube (Ruse).

Project Rail2Sea (Three Seas Initiative)

Connecting Constanța (Romania) with Gdańsk (Poland), passing through Hungary and Slovakia — the main north-south freight artery of Eastern Europe.

Via Carpathia Highway

Extending from Lithuania (Klaipėda) to Greece (Thessaloniki) via the Egnatia Odos vertical axes — enabling seamless truck distribution across nine countries.

Solidarity Lanes — Ukraine

Since 2022, the Vertical Corridor carries the majority of Ukrainian exports and imports, significantly accelerating EU funding and permitting across all projects.

Funding Sources
CEF II · EIB · RRF (Recovery & Resilience)
APG Position
Southern Terminus · Aegean Sea Gateway
North–South Pharmaceutical Corridor
Baltic
Klaipėda / Gdańsk
Via Carpathia northern terminus
Poland
Warsaw / Lublin
Ukraine / Romania
Kyiv / Constanța
Solidarity Lanes · Rail2Sea
Bulgaria
Sofia / Burgas / Varna
Sea2Sea rail connection
Northern Greece · APG HUB
Alexandroupolis / Thessaloniki
Package · Serialize · Release
Eastern Mediterranean
India / Gulf / IMEC
CMA, IMEC origins

Who We Serve

APG is designed for organizations that need faster, structured access to European pharmaceutical markets without building their own infrastructure in every country.

Manufacturers & Exporters

Companies seeking faster, structured EU access without building their own packaging and logistics footprint in every target market. Ideal for Indian, Gulf and Asian manufacturers entering the EU.

Regional Distributors

Organizations needing a compliant supply node that supports multi-country packaging and distribution requirements across CEE — from a single, auditable platform.

Logistics & Infrastructure Partners

Carriers, operators and freight forwarders aligned with a strategic pharmaceutical corridor into the European hinterland — seeking a reliable, regulated hub partner.

Institutional & Financial Stakeholders

Parties interested in a platform at the intersection of pharmaceutical compliance, infrastructure and EU-facing trade growth — at an inflection point in global supply chain architecture.

APG at a Glance

The Numbers Behind the Gateway

50%
Faster CEE access vs. northern European ports
6h
Minimum road delivery time to Bulgaria & nearby CEE markets
1
Single EU entry point for all target markets
2–8°C
Cold chain capability for biosimilars & biologics

*vs. Rotterdam/Hamburg transhipment to Sofia — based on published port transit data and Vertical Corridor road/rail schedules.

Location
Northern Greece
Logistics / free-zone ecosystem
Regulatory
EU GMP / GDP Aligned
Single compliant platform for all markets
Current Stage
Development & Pre-Licensing Phase
Active partner & investor engagement
Get in Touch

Ready to Explore a Strategic Partnership?

Whether you are a pharma manufacturer seeking EU market access, a logistics partner, or an investor — we are open to structured conversations. Our detailed Business Plan and technical specifications are available under NDA to qualified partners and investors.

Our Proposition
✓ Full GMP/GDP compliance
✓ Faster access to CEE markets
✓ EU-India FTA / IMEC opportunities
✓ Multimodal logistics advantage
✓ Flexible batch splitting
✓ Cold chain for high-value products
✓ Scalable infrastructure
✓ CMA corridor alignment

Start the Conversation

Tell us briefly who you are and what you are looking for. We will follow up within 2 business days.

NDA Notice: Our Business Plan and financial projections are shared under a mutual NDA. We will send you the NDA document with our first reply.

By submitting, you agree to our Privacy Policy. We never share your data with third parties.

Legal Notice & Corporate Imprint

Corporate Identity

Corporate Name: AIGIS FARMAKEFTIKOS KOMVOS P.C.
Commercial Title: APG — AEGIS Pharma Gateway
Legal Form: Private Company (IKE), operating under the laws of the Hellenic Republic
GEMI No.: 192327203000
VAT No.: EL 803217190
Tax Office: KEFODE Attikis
Registered Address: Konitsis 25, 15125 Maroussi, Greece
Legal Representative: Raphael Diogenis Pantazis, Managing Director

Regulatory Disclosure

AEGIS Pharma Gateway (APG) is currently in its development and pre-licensing phase. The company does not yet hold pharmaceutical manufacturing, packaging, or distribution authorizations. All references to operational capabilities represent targets contingent on facility completion, equipment validation, and formal licensing by competent authorities (EOF / EMA).

Investor Disclaimer

Content on this platform is for general informational purposes only. It does not constitute a formal investment prospectus, solicitation, or public offer. All forward-looking statements are indicative forecasts. Actual results may differ materially. AEGIS Pharma Gateway IKE, its founders, and directors accept no liability for decisions made based on this information.

All content and designs are the exclusive intellectual property of AEGIS Pharma Gateway® (Hellenic IPO, Reg. 8928/2026). Personal data processed in accordance with GDPR (EU) 2016/679 and Greek Law 4624/2019. Governing law: Hellenic Republic. Jurisdiction: Courts of Athens, Greece.